Global health & development

Debate around health systems often focuses on lives saved by new or improved medicines and fails to consider the long-term development of scientific research capacity in low and middle income countries, and how this affects the health of a country’s population and its economic growth. A recognition that health, education and industrial policy are interlinked is at the core of Innogen’s approach.

Projects

Innogen retreat 2019

10 October 2019

This year's annual meeting took place 3-4 October in Edinburgh and it brought together researchers from the Open University and the University of Edinburgh as well as colleagues from the Open University Scotland. 

Meet our Researchers: Dr Katie Adam

20 February 2020

We speak with Dr Katie Adam, a Postdoctoral Research Fellow working on interdisciplinary animal health projects. She trained as a veterinary surgeon at the Royal (Dick) School of Veterinary Studies in Edinburgh and holds a master’s degree in Aquatic Medicine from the Norwegian School of Veterinary Science. Before joining Innogen, she worked in clinical veterinary practice and as a field epidemiologist, researching endemic animal diseases. 

Innogen contributes to TIBA initiatives

27 June 2019

Geoff Banda, Innogen co-Director and TIBA Work Package leader, has been involved in delivering an intellectual property workshop in Johannesburg and the development of the ‘Research for Health and Innovation Strategy for Africa’.

Innogen Research on Covid-19

27 March 2020

Recent publications by Innogen members draw attention to lessons learnt from previous outbreaks of infectious disease, and to the importance of ‘local health’ and the law in global health emergencies.

The role of social sciences in innovation

18 November 2019

As part of the ESRC Festival of Social Science, the Innogen Institute brought together social science researchers and scientists from the Roslin Institute and the Centre for Synthetic and Systems Biology (SynthSys) at the University of Edinburgh for a free public event exploring the opportunities arising from the latest genetic technologies and the regulatory issues they are facing.